Febsan 40/Febsan 80

Febsan 40/Febsan 80

febuxostat

Manufacturer:

SRS Pharma

Distributor:

Triple Tact

Marketer:

A-Z Med Inc
Concise Prescribing Info
Contents
Febuxostat
Indications/Uses
Chronic management of hyperuricemia in patients w/ gout.
Dosage/Direction for Use
Initially 40 mg once daily. Patient who do not achieve a serum uric acid <6 mg/dL after 2 wk w/ 40 mg 80 mg once daily.
Administration
May be taken with or without food: May be taken w/o regard to antacid use.
Contraindications
Concurrent treatment w/ azathioprine, mercaptopurine & theophylline.
Special Precautions
Potential for gout flares, elevated liver enzymes & adverse CV events after initiation of therapy. Consider concomitant prophylaxis w/ NSAID or colchicine for gout flares. Monitor for rash, chest pain, shortness of breath or neurologic symptoms suggesting a stroke. Not recommended for the treatment of asymptomatic hyperuricemia; patients in whom the rate of urate formation is greatly increased (eg, malignant disease & its treatment, Lesch-Nyhan syndrome). Severe renal (CrCl <30 mL/min) & hepatic (Child-Pugh class C) impairment. Pregnancy & lactation.
Adverse Reactions
Liver function abnormalities, nausea, arthralgia & rash. Diarrhea, headache, musculoskeletal stiffness, constipation, GERD, flushing, dizziness & gout flares.
Drug Interactions
May cause increased plasma conc of drugs metabolized by XO (eg, theophylline, mercaptopurine, azathioprine).
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Presentation/Packing
Form
Febsan 40 FC tab 40 mg
Packing/Price
10's
Form
Febsan 80 FC tab 80 mg
Packing/Price
10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in